BAYRY Price and Sentiment
BAYRY Latest news
ST. LOUIS--(BUSINESS WIRE)--Harvest is a time for North American farmers to reflect on the past season's successes and challenges, while looking ahead to what's next. Bayer – with No. 1 market positions in corn, soybean and cotton acres in the U.S. – is also excited about the future and the next round of cutting-edge technologies for growers in 2022 and beyond. Among Bayer's milestones during the 2021 season: XtendFlex® Soybeans Launch: As Bayer's second major soybean trait launch in the last f
ESSA Pharma developed a novel mode of action drug, EPI-7386, for the treatment of metastatic castrate-resistant prostate cancer. Pre-clinical and early Ph 1 results are promising. ESSA's share price crashed in mid-Aug when a change in the Ph 1 trial protocol was announced, and a delay in the expected Ph 1 monotherapy trial data release. I believe the market overreacted.
Investing in Bayer isn't for the faint-hearted given the company's recent and likely future valuation and earnings volatility. However, beneath the hood there's a qualitative company with superb fundamentals and an excellent portfolio.
Bayer Aktiengesellschaft (BAYZF) CEO Werner Baumann on Q3 2021 Results - Earnings Call Transcript
Bayer's (BAYRY) earnings in the third quarter of 2021 beat estimates. Revenues surge year over year.
German pharmaceutical-and-chemical conglomerate Bayer AG on Tuesday swung to a profit for the third quarter and said sales rose, driven by a recovery in its agriculture business.
Bayer said on Tuesday the head of its crop science unit, Liam Condon, would quit at the end of the year to pursue other career opportunities, following disappointing results earlier this year.
Bayer Presents New Subgroup Analysis of Prespecified Pooled Analysis of Phase III Studies for KERENDIA® (finerenone) for Chronic Kidney Disease Associated With Type 2 Diabetes With or Without SGLT2i Use at Baseline2021-11-08 08:00
WHIPPANY, N.J.--(BUSINESS WIRE)--Bayer announced a new subgroup analysis of the prespecified pooled analysis, FIDELITY, which analyzed kidney and cardiovascular (CV) outcomes versus placebo by baseline sodium-glucose co-transporter-2 inhibitor (SGLT2i) use.1 These results add to the growing body of data on the renal and CV outcomes of KERENDIA® (finerenone), the first nonsteroidal mineralocorticoid receptor antagonist (MRA) for adult patients with chronic kidney disease (CKD) associated with ty
WHIPPANY, N.J.--(BUSINESS WIRE)--For the second consecutive year, the Bayer Consumer Health Media Team has been selected as the winner in the Best In-House Media Operations category during the 2021 AdExchanger Awards. The team also earned Best In Show for Overall Excellence in Programmatic Media. The AdExchanger Awards celebrate excellence in digital marketing and advertising. “Our in-house approach harnesses the power and passion of our employees as no one knows our business and brands better
Agricultural seeds and chemicals supplier Bayer AG is expanding its carbon farming program to members of U.S. farm cooperative CHS Inc, boosting incentives for members to participate in the program, the companies said on Wednesday.